CancerDrs Find care

Thyroid Cancer clinical trials in Maryland

13 actively recruiting thyroid cancer trials at 11 sites across Maryland.

Data from ClinicalTrials.gov · last refreshed

Phase 1, Phase 2 Recruiting Industry

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and recommended Phase 2 dose (RP2D) of repotrectinib given to adult subjects with adv…

Sponsor: Turning Point Therapeutics, Inc.
NCT ID: NCT03093116
Sites in Maryland:
  • Local Institution - 2133 — Baltimore, Maryland
View on ClinicalTrials.gov →
Phase 2 Recruiting NIH

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Background: About 5% to 10% of differentiated thyroid cancers become resistant to standard treatment with radioactive iodine. In these cases, treatment options are limited and generally not effective. Researchers want to see if they can be…

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT ID: NCT04927416
Sites in Maryland:
  • National Institutes of Health Clinical Center — Bethesda, Maryland
View on ClinicalTrials.gov →
Phase 2 Recruiting NIH

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

Study rationale High risk patients with differentiated thyroid cancer (DTC) require therapy with 131 I under thyroid stimulating hormone (TSH) stimulation. There are two methods of TSH stimulation endogenous by thyroid hormone withdrawal (…

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT ID: NCT03841617
Sites in Maryland:
  • National Institutes of Health Clinical Center — Bethesda, Maryland
View on ClinicalTrials.gov →
Phase 1 Recruiting Academic/Other

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

The goal of this study is to evaluate combined radioactive iodine (RAI, 131-I) and external beam radiotherapy (XRT) to optimize the radiation dose delivered to treat well differentiated thyroid cancers (DTC) with iodine-avid metastases. Th…

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT ID: NCT04892303
Sites in Maryland:
  • The Johns Hopkins SKCCC — Baltimore, Maryland
View on ClinicalTrials.gov →
Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05334069
Sites in Maryland:
  • Mercy Medical Center — Baltimore, Maryland
  • Sinai Hospital of Baltimore — Baltimore, Maryland
  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute — Baltimore, Maryland
  • Walter Reed National Military Medical Center — Bethesda, Maryland
  • University of Maryland Shore Medical Center at Easton — Easton, Maryland
View on ClinicalTrials.gov →
Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska
NCT ID: NCT02012699
Sites in Maryland:
  • Northwest Hospital — Randallstown, Maryland
  • William E. Kahlert Regional Cancer Center — Westminster, Maryland
View on ClinicalTrials.gov →
Recruiting NIH

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

Background: \- Pleuropulmonary blastoma (PPB) is a rare fast-growing lung tumor that is associated with other, rare tumor types. Most cases of PPB appear in children younger than 6 years of age. Recently, it has been shown that this condit…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT01247597
Sites in Maryland:
  • National Institutes of Health Clinical Center — Bethesda, Maryland
  • National Cancer Institute - Shady Grove — Rockville, Maryland
View on ClinicalTrials.gov →
Recruiting NIH

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

Background: \- Researchers are studying types of thyroid cancer that seem to cluster in families. Non-medullary thyroid cancer accounts for the vast majority of all types of thyroid cancer, but little is known about possible genes that may…

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT ID: NCT01109420
Sites in Maryland:
  • National Institutes of Health Clinical Center — Bethesda, Maryland
View on ClinicalTrials.gov →
Recruiting NIH

Studies on Tumors of the Thyroid

Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and …

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT ID: NCT00001160
Sites in Maryland:
  • National Institutes of Health Clinical Center — Bethesda, Maryland
View on ClinicalTrials.gov →
Recruiting NIH

Natural History Study of Children and Adults With Medullary Thyroid Cancer

Background: \- Medullary thyroid cancer (MTC) is a rare cancer of the thyroid gland. In children and adults, it is often part of a condition called Multiple Endocrine Neoplasia 2 (MEN2). MEN2 is usually caused by a genetic mutation, and it…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT01660984
Sites in Maryland:
  • National Institutes of Health Clinical Center — Bethesda, Maryland
View on ClinicalTrials.gov →
Recruiting NIH

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Background: * Endocrine neoplasms (tumors) are among the fastest growing tumors in incidence in the United States. Furthermore, it is often difficult to distinguish between benign or malignant tumors in cancers of the thyroid, parathyroid,…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT01005654
Sites in Maryland:
  • National Institutes of Health Clinical Center — Bethesda, Maryland
View on ClinicalTrials.gov →
NA Recruiting Academic/Other

Personalized Treatment in Thyroid Disorders

The Collar Therapy Indicator (CoTI) (A device that is placed in collar around the neck resembling a turtle neck sweater collar with a wire and recording box) has been shown in a single small previously published experience to provide data …

Sponsor: Johns Hopkins University
NCT ID: NCT03517579
Sites in Maryland:
  • Johns Hopkins Hospital — Baltimore, Maryland
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20